John Matsoukas has over 30 years of experience in research in the field of Organic and Peptide Chemistry, Nuclear Magnetic Resonance (NMR) and in the Chemistry of Natural Products. He has studied Chemistry at the University of Patras, Greece. He graduated from the University of New Brunswick in Canada with an MSc degree in Chemistry. His dissertation was in the total synthesis of natural products and Nuclear Magnetic Resonance. He carried out his Ph.D. studies in Chemistry at the University of Patras, Greece in the peptide field. He joined the University of Calgary, Alberta, Canada working on Angiotensins and Angiotensin Receptor antagonists. He is the leader of an international network for multiple sclerosis research clinical investigation of potential drugs discovered in his group. His work, supported by extensive funding for competitive grants, led to potential vaccines, candidates to be evaluated in human Phase I clinical trial. He is an Adjunct Professor at the Victoria University, Australia and the University of Calgary, Canada.